NR4A1 and acute myeloid leukemia: Given the central role of MYC as a key oncogenic driver of AML, and the identification of a conserved SE predicted to control MYC expression in a broad range of cytogenetically distinct AMLs, we focused on this gene to understand how NR4A1 and DHE regulate SE-dependent MYC expression.